Literature DB >> 24184507

Identification and characterization of phosphorylation sites within the pregnane X receptor protein.

Ayesha Elias1, Anthony A High2, Ashutosh Mishra2, Su Sien Ong1, Jing Wu1, Junmin Peng3, Taosheng Chen4.   

Abstract

Pregnane X receptor (PXR) is a xenobiotic sensor regulating the expression of genes involved in xenobiotic detoxification and elimination. Phosphorylation plays an important role in modulating PXR activity and several phosphorylation sites have been predicted and characterized in in vitro experiments. Although PXR has been shown to be a phosphoprotein in vivo, the exact residues that are phosphorylated remain elusive. Using mass spectrometry, we identified for the first time S114, T133/135, S167, and S200 residues that are phosphorylated in PXR following an in vitro kinase assay using cyclin-dependent kinase 2. We further found that the phosphorylation at S114, T133, and T135 occurred in PXR isolated from cells. We tested the phosphodeficient and phosphomimetic mutants corresponding to all the sites identified and determined that phosphorylation at S114 attenuates the transcriptional activity of PXR, consistent with the observation that the S114D mutant displayed reduced association with the PXR-targeted DNA response element. Phosphomimetic mutations at either T133 or T135 did not show a significant change in transcriptional activity however, the dual phosphomimetic mutant T133D/T135D displayed reduced transcriptional activity. Subcellular localization studies showed a varied distribution of the mutants suggesting that the regulation of PXR is much more complex than what we can observe by just overexpressing the mutants. Thus, our results provide the first direct evidence that PXR is phosphorylated at specific residues and suggest that further investigation is warranted to fully understand the regulation of PXR by phosphorylation.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug metabolism; PXR; Phosphomimetic Mutations.; Phosphorylation

Mesh:

Substances:

Year:  2013        PMID: 24184507      PMCID: PMC3947193          DOI: 10.1016/j.bcp.2013.10.015

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  30 in total

Review 1.  The regulation of protein function by multisite phosphorylation--a 25 year update.

Authors:  P Cohen
Journal:  Trends Biochem Sci       Date:  2000-12       Impact factor: 13.807

2.  Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase C.

Authors:  Xunshan Ding; Jeff L Staudinger
Journal:  Biochem Pharmacol       Date:  2005-01-21       Impact factor: 5.858

3.  Regulation and binding of pregnane X receptor by nuclear receptor corepressor silencing mediator of retinoid and thyroid hormone receptors (SMRT).

Authors:  David R Johnson; Chia-Wei Li; Liuh-Yow Chen; Jagadish C Ghosh; J Don Chen
Journal:  Mol Pharmacol       Date:  2005-10-11       Impact factor: 4.436

4.  Regulation of pregnane X receptor (PXR) function and UGT1A1 gene expression by posttranslational modification of PXR protein.

Authors:  Junko Sugatani; Takahiro Uchida; Masatoshi Kurosawa; Masahiko Yamaguchi; Yasuhiro Yamazaki; Akira Ikari; Masao Miwa
Journal:  Drug Metab Dispos       Date:  2012-07-24       Impact factor: 3.922

Review 5.  Phosphorylation: a fundamental regulator of steroid receptor action.

Authors:  Lindsey S Treviño; Nancy L Weigel
Journal:  Trends Endocrinol Metab       Date:  2013-07-06       Impact factor: 12.015

6.  Active ERK1/2 protein interacts with the phosphorylated nuclear constitutive active/androstane receptor (CAR; NR1I3), repressing dephosphorylation and sequestering CAR in the cytoplasm.

Authors:  Makoto Osabe; Masahiko Negishi
Journal:  J Biol Chem       Date:  2011-08-26       Impact factor: 5.157

7.  Cyclic AMP-dependent protein kinase signaling modulates pregnane x receptor activity in a species-specific manner.

Authors:  Kristin Lichti-Kaiser; Chenshu Xu; Jeff L Staudinger
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

8.  A predictive scale for evaluating cyclin-dependent kinase substrates. A comparison of p34cdc2 and p33cdk2.

Authors:  J K Holmes; M J Solomon
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

9.  A systematic analysis of predicted phosphorylation sites within the human pregnane X receptor protein.

Authors:  Kristin Lichti-Kaiser; Dan Brobst; Chenshu Xu; Jeff L Staudinger
Journal:  J Pharmacol Exp Ther       Date:  2009-07-17       Impact factor: 4.030

10.  Effects of natural flavones and flavonols on the kinase activity of Cdk5.

Authors:  Gerald Zapata-Torres; Felipe Opazo; Cristián Salgado; Juan Pablo Muñoz; Hans Krautwurst; Carolina Mascayano; Silvia Sepúlveda-Boza; Ricardo B Maccioni; Bruce K Cassels
Journal:  J Nat Prod       Date:  2004-03       Impact factor: 4.050

View more
  19 in total

1.  SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes.

Authors:  Wenqi Cui; Mengxi Sun; Nadezhda Galeva; Todd D Williams; Yoshiaki Azuma; Jeff L Staudinger
Journal:  Drug Metab Dispos       Date:  2015-06-10       Impact factor: 3.922

Review 2.  Pregnane X receptor and drug-induced liver injury.

Authors:  Yue-Ming Wang; Sergio C Chai; Christopher T Brewer; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-09-25       Impact factor: 4.481

Review 3.  Drug discovery technologies to identify and characterize modulators of the pregnane X receptor and the constitutive androstane receptor.

Authors:  Sergio C Chai; Wenwei Lin; Yongtao Li; Taosheng Chen
Journal:  Drug Discov Today       Date:  2019-02-04       Impact factor: 7.851

Review 4.  Small-molecule modulators of PXR and CAR.

Authors:  Sergio C Chai; Milu T Cherian; Yue-Ming Wang; Taosheng Chen
Journal:  Biochim Biophys Acta       Date:  2016-02-24

5.  Nuclear Receptors in Drug Metabolism, Drug Response and Drug Interactions.

Authors:  Chandra Prakash; Baltazar Zuniga; Chung Seog Song; Shoulei Jiang; Jodie Cropper; Sulgi Park; Bandana Chatterjee
Journal:  Nucl Receptor Res       Date:  2015

Review 6.  Mechanisms of xenobiotic receptor activation: Direct vs. indirect.

Authors:  Bryan Mackowiak; Hongbing Wang
Journal:  Biochim Biophys Acta       Date:  2016-02-10

7.  Role of c-Jun-N-Terminal Kinase in Pregnane X Receptor-Mediated Induction of Human Cytochrome P4503A4 In Vitro.

Authors:  Guncha Taneja; Chun Chu; Paramahamsa Maturu; Bhagavatula Moorthy; Romi Ghose
Journal:  Drug Metab Dispos       Date:  2018-02-12       Impact factor: 3.922

8.  Acetylation of lysine 109 modulates pregnane X receptor DNA binding and transcriptional activity.

Authors:  Danielle Pasquel; Aneta Doricakova; Hao Li; Sandhya Kortagere; Matthew D Krasowski; Arunima Biswas; William G Walton; Matthew R Redinbo; Zdenek Dvorak; Sridhar Mani
Journal:  Biochim Biophys Acta       Date:  2016-02-23

Review 9.  Post-translational and post-transcriptional modifications of pregnane X receptor (PXR) in regulation of the cytochrome P450 superfamily.

Authors:  Tomas Smutny; Sridhar Mani; Petr Pavek
Journal:  Curr Drug Metab       Date:  2013-12       Impact factor: 3.731

10.  Pregnane X Receptor and Cancer: Context-Specificity is Key.

Authors:  Satyanarayana R Pondugula; Petr Pavek; Sridhar Mani
Journal:  Nucl Receptor Res       Date:  2016-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.